Medtronic is almost exactly a year into the behemoth integration of Covidien. Chairman and CEO Omar Ishrak took the company’s presentation at the ongoing J.P. Morgan Healthcare Conference in San Francisco as an opportunity to make the case for the medical device giant as a stock that’s able to return a brisk “double-digit” rate of return to investors.